Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Hatzl S, Posch F, Rezai A, Gornicec M, Beham-Schmid C, Magnes T, Wangner S, Deutsch A, Greinix H, Uhl B, Prochazka KT, Egle A, Greil R, Melchardt T, Linkesch W, Schulz E, Neumeister P. Hatzl S, et al. Among authors: neumeister p. Support Care Cancer. 2021 Sep;29(9):5197-5207. doi: 10.1007/s00520-021-06059-2. Epub 2021 Feb 24. Support Care Cancer. 2021. PMID: 33625586 Free PMC article.
The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Troppan KT, Melchardt T, Deutsch A, Schlick K, Stojakovic T, Bullock MD, Reitz D, Beham-Schmid C, Weiss L, Neureiter D, Wenzl K, Greil R, Neumeister P, Egle A, Pichler M. Troppan KT, et al. Among authors: neumeister p. Eur J Haematol. 2015 Dec;95(6):538-44. doi: 10.1111/ejh.12529. Epub 2015 Mar 26. Eur J Haematol. 2015. PMID: 25677782
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Prochazka KT, Melchardt T, Posch F, Schlick K, Deutsch A, Beham-Schmid C, Weiss L, Gary T, Neureiter D, Klieser E, Greil R, Neumeister P, Egle A, Pichler M. Prochazka KT, et al. Among authors: neumeister p. Br J Cancer. 2016 Nov 8;115(10):1264-1272. doi: 10.1038/bjc.2016.325. Epub 2016 Oct 20. Br J Cancer. 2016. PMID: 27764838 Free PMC article.
The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma.
Hatzl S, Posch F, Schulz E, Gornicec M, Deutsch A, Beham-Schmid C, Pichler M, Greinix H, Sill H, Zebisch A, Neumeister P, Prochazka KT. Hatzl S, et al. Among authors: neumeister p. Pathol Oncol Res. 2020 Oct;26(4):2831-2833. doi: 10.1007/s12253-020-00864-6. Epub 2020 Jun 29. Pathol Oncol Res. 2020. PMID: 32602002 Free article. No abstract available.
C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients.
Troppan KT, Schlick K, Deutsch A, Melchardt T, Egle A, Stojakovic T, Beham-Schmid C, Weiss L, Neureiter D, Wenzl K, Greil R, Neumeister P, Pichler M. Troppan KT, et al. Among authors: neumeister p. Br J Cancer. 2014 Jul 8;111(1):55-60. doi: 10.1038/bjc.2014.277. Epub 2014 May 29. Br J Cancer. 2014. PMID: 24874478 Free PMC article.
122 results